Drugs / Low Titer O Whole Blood
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05638581 Comparator | Jul 2023 → Aug 2026 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low Titer O Whole Blood | “Participants will receive Low Titer O Whole Blood administered intravenously or intraosseously.” NCT05638581 ↗ |
| Known as | LTOWB | “The TROOP trial will include injured adults with hemorrhagic shock anticipated to require massive blood transfusions, who will be randomized to receive either whole blood...” NCT05638581 ↗ |
| Route | Intravenous | “administered intravenously” NCT05638581 ↗ |